Description

Canada and the European Union (EU) officially recognized good manufacturing practices (GMP) inspections conducted outside of their respective jurisdictions as of April 1, 2021. The extra-jurisdictional inspections are outlined in the Comprehensive Economic and Trade Agreement (CETA)’s protocol on pharmaceuticals. This protocol is known as the Protocol on the Mutual Recognition of the Compliance and Enforcement Programme regarding Good Manufacturing Practices for Pharmaceutical Products.

Resources

Name	Format	Description	Link
Canada and EU recognize good manufacturing practices extra-jurisdictional inspection outcomes before April 1, 2021	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/drug-establishment-licensing-bulletin/canada-european-union-good-manufacturing-practices-extra-jurisdictional-inspection.html
Canada and EU recognize good manufacturing practices extra-jurisdictional inspection outcomes before April 1, 2021	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/conformite-application-loi/licences-etablissement/bulletin-licences-etablissement-pharmaceutiques/canada-union-europeenne-inspections-bonnes-pratiques-fabrication-extraterritoriales.html

Tags

Topics

Categories